E. G. INEK Et Al. , "Spironolactone Reduces Galectin-3 Levels in Mildly Symptomatic Systolic Heart Failure Patients," Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association , vol.128, Texas, United States Of America, 2013
INEK, E. G. Et Al. 2013. Spironolactone Reduces Galectin-3 Levels in Mildly Symptomatic Systolic Heart Failure Patients. Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association , (Texas, United States Of America).
INEK, E. G., Suljevic, S. A., Demirel, H., KARALOK, N., & Güray, Y., (2013). Spironolactone Reduces Galectin-3 Levels in Mildly Symptomatic Systolic Heart Failure Patients . Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association, Texas, United States Of America
INEK, ŞENAY Et Al. "Spironolactone Reduces Galectin-3 Levels in Mildly Symptomatic Systolic Heart Failure Patients," Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association, Texas, United States Of America, 2013
INEK, ŞENAY Et Al. "Spironolactone Reduces Galectin-3 Levels in Mildly Symptomatic Systolic Heart Failure Patients." Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association , Texas, United States Of America, 2013
INEK, E. G. Et Al. (2013) . "Spironolactone Reduces Galectin-3 Levels in Mildly Symptomatic Systolic Heart Failure Patients." Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association , Texas, United States Of America.
@conferencepaper{conferencepaper, author={ŞENAY AKIN Et Al. }, title={Spironolactone Reduces Galectin-3 Levels in Mildly Symptomatic Systolic Heart Failure Patients}, congress name={Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association}, city={Texas}, country={United States Of America}, year={2013}}